ADXN
Addex Therapeutics LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.16M
P/E Ratio
—
EPS
$-9.00
Beta
1.97
52W High
$12.05
52W Low
$5.41
50-Day MA
$6.67
200-Day MA
$7.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Addex Therapeutics Ltd
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.
Fundamentals
| Revenue (TTM) | 172,860 |
| Gross Profit (TTM) | -498,791 |
| EBITDA | $-2.81M |
| Operating Margin | -4923.00% |
| Return on Equity | -94.80% |
| Return on Assets | -20.60% |
| Revenue/Share (TTM) | $0.24 |
| Book Value | $4.81 |
| Price-to-Book | 1.31 |
| Price-to-Sales (TTM) | 47.23 |
| EV/Revenue | 159.18 |
| EV/EBITDA | -0.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 950.00% |
| Shares Outstanding | $1.27M |
| Float | $1.03M |
| % Insiders | 0.00% |
| % Institutions | 0.05% |
Historical Volatility
HV 10-Day
92.81%
HV 20-Day
67.83%
HV 30-Day
56.90%
HV 60-Day
72.84%
HV Rank
11.9%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026